Publicaciones en las que colabora con Jordi A. Matías-Guiu (26)

2022

  1. Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging

    Frontiers in Aging Neuroscience, Vol. 13

2021

  1. Personalized Repetitive Transcranial Magnetic Stimulation for Primary Progressive Aphasia

    Journal of Alzheimer's disease : JAD, Vol. 84, Núm. 1, pp. 151-167

2020

  1. Amyloid PET findings in multiple sclerosis are associated with cognitive decline at 18 months

    Multiple Sclerosis and Related Disorders, Vol. 39

  2. Amyloid Positron Emission Tomography in Multiple Sclerosis: Between Amyloid Deposition and Myelin Damage

    Annals of Neurology

2019

  1. Inhibition impairment in frontotemporal dementia, amyotrophic lateral sclerosis, and Alzheimer’s disease: clinical assessment and metabolic correlates

    Brain Imaging and Behavior, Vol. 13, Núm. 3, pp. 651-659

  2. Machine learning in the clinical and language characterisation of primary progressive aphasia variants

    Cortex, Vol. 119, pp. 312-323

2018

  1. Clustering analysis of FDG-Pet imaging in primary progressive aphasia

    Frontiers in Aging Neuroscience, Vol. 10, pp. 1-12

  2. Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease

    Journal of Alzheimer's Disease, Vol. 61, Núm. 1, pp. 103-111

  3. Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease

    International Journal of Geriatric Psychiatry, Vol. 33, Núm. 1, pp. 141-150

2017

  1. Amyloid PET in pseudotumoral multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 15, pp. 15-17

  2. Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology

    Prion, Vol. 11, Núm. 3, pp. 205-213

  3. Episodic Memory Dysfunction in Behavioral Variant Frontotemporal Dementia: A Clinical and FDG-PET Study

    Journal of Alzheimer's Disease, Vol. 57, Núm. 4, pp. 1251-1264

  4. FDG-PET/CT or MRI for the diagnosis of primary progressive aphasia?

    American Journal of Neuroradiology

  5. Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints

    American Journal of Geriatric Psychiatry, Vol. 25, Núm. 7, pp. 730-740

  6. Reading difficulties in primary progressive aphasia in a regular language-speaking cohort of patients

    Neuropsychologia, Vol. 101, pp. 132-140

2016

  1. 18F-FDG PET/TC y RM funcional en un caso de afasia progresiva primaria logopénica cruzada

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 35, Núm. 6, pp. 394-397

  2. Amyloid proteins and their role in multiple sclerosis. Considerations in the use of amyloid-PET imaging

    Frontiers in Neurology, Vol. 7, Núm. MAR

  3. Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, Núm. 11, pp. 2050-2060

  4. Pittsburgh compound B and other amyloid positron emission tomography tracers for the study of white matter and multiple sclerosis

    Annals of Neurology

2015

  1. Amyloid PET imaging in multiple sclerosis: An 18F-florbetaben study

    BMC Neurology, Vol. 15, Núm. 1